Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ )Iu0MN&
+9EG6"..@H
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© m5i?<Ko@
->"Z1
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© O7D aVlln
d2'1
6.lV
1.Co-stimulators (or co-stimulating molecules) j_]#Ew\q
3i\<#{
2.NK-kB ,%Go.3i[
lqaOLZH
3.Immunoglobulin superfamily nulLK28q
7LotN6H
4.antigen-presenting cell (APC) P|U9f6^3
2
Q bCH}
5.death domain *I)F5M
/Py1Q
6.CCR and CXCR >~+qU&'2
WR:I2-1
7.Lectin (or mitogen) )#%v1rR
OV>JmYe1{/
8.Clusters of differentiation, CD) 5EX
Ghc'
yq6Gyoi<
9.B7 family m7$t$/g
Ea<kc[Q
10.Cytotoxic T lymphocyte, CTL) B!j7vXM2
;N(9n
X}%)
11.IL-15 and IL-15 receptor (IL-15R) U*Sjb%
Qb
cqd}.D
12.MHC restriction z%lLbKSe
(q
yT,K8
13.Affinity-chromatography BJ*8mKi h
+3d.JQoKl
14.Cyctosprin A, CsA goje4;
Ge_Gx*R
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) %=*nJvYS
&P:2`\'
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 5
fDp"-
h anS8
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 cOoF +hz0O
o,yZ1"
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ @AfC$T
h8
!(WO!
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ i5 ;_
/r?EY
&9G
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© f=cj5T:[
XCyAt;neon
ÃâÒßѧרҵ£º
/oC@:7
=u<jxV9
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ ]yV,lp
[J\! 2\Oo
Ïû»¯ÄÚ¿Æ£º "?Yf3G: \0
S]g`Ds<
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ b
FB.hkTP
ojbms>a
ѪҺ²¡Ñ§×¨Òµ£º z;lWr(-x
N?l
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿